Description: TransMedics, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. The company offers Organ Care System (OCS), an integrated, compact, portable preservation technology that addresses unmet need for organs for transplantation. Its Organ Care System preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Its Organ Care System incudes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains organs in a near physiologic state and enables surgeons to perfuse and ventilate the organ between the donor and recipient sites; OCS Heart, a portable heart perfusion system that helps to maintain organs in a warm functioning state outside of the body; and OCS Liver, a portable perfusion and monitoring system that maintains organs in a near physiologic state. The company offers its products in the United States and internationally. TransMedics, Inc. is headquartered in Andover, Massachusetts. TransMedics, Inc. is a subsidiary of Transmedics Group, Inc.
Home Page: www.transmedics.com
TMDX Technical Analysis
200 Minuteman Road
Andover,
MA
01810
United States
Phone:
978 552 0900
Officers
Name | Title |
---|---|
Dr. Waleed H. Hassanein M.D. | Founder, Pres, MD, CEO & Director |
Mr. Stephen Gordon | CFO. Treasurer & Sec. |
Dr. Tamer I. Khayal M.D. | Chief Commercial Officer |
Ms. Miriam C. Provost Ph.D. | VP of Global Regulatory Affairs |
Ms. Laura Damme | VP of Clinical Affairs |
Mr. John F. Carey | VP of Operations |
Mr. Mark Anderson | Sr. Director of Technology Devel. |
Ms. Susan Goodman | VP of HR |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: |
Forward PE: | 0 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 9.9924 |
Price-to-Sales TTM: | 26.4418 |
IPO Date: | 2019-05-02 |
Fiscal Year End: | December |
Full Time Employees: | 148 |